These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium. Donker GA; Spreeuwenberg P; Bartelds AI; van der Velden K; Foets M Fam Pract; 2000 Dec; 17(6):508-13. PubMed ID: 11120723 [TBL] [Abstract][Full Text] [Related]
27. Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium. Antoine C; Ameye L; Moreau M; Paesmans M; Rozenberg S Climacteric; 2011 Aug; 14(4):464-71. PubMed ID: 21545271 [TBL] [Abstract][Full Text] [Related]
28. Use of hormone replacement therapy among Danish nurses at increased risk of osteoporosis. Hundrup YA; Thoning H; Rasmussen NK; Obel EB; Philip J Int J Behav Med; 2003; 10(3):269-83. PubMed ID: 14525721 [TBL] [Abstract][Full Text] [Related]
29. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older. Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068 [TBL] [Abstract][Full Text] [Related]
31. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994 [TBL] [Abstract][Full Text] [Related]
32. Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study. Nørgaard M; Poulsen AH; Pedersen L; Gregersen H; Friis S; Ewertz M; Johnsen HE; Sørensen HT Br J Cancer; 2006 May; 94(9):1339-41. PubMed ID: 16670705 [TBL] [Abstract][Full Text] [Related]
33. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517 [TBL] [Abstract][Full Text] [Related]
34. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study. Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649 [TBL] [Abstract][Full Text] [Related]
35. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781 [TBL] [Abstract][Full Text] [Related]
36. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI. Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155 [TBL] [Abstract][Full Text] [Related]
37. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial. Leung KY; Ling M; Tang GW Maturitas; 2005; 52(3-4):277-85. PubMed ID: 15950409 [TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462 [TBL] [Abstract][Full Text] [Related]
39. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Olesen C; Steffensen FH; Nielsen GL; de Jong-van den Berg L; Olsen J; Sørensen HT Eur J Clin Pharmacol; 1999 Apr; 55(2):139-44. PubMed ID: 10335909 [TBL] [Abstract][Full Text] [Related]